AUXILIUM ANNOUNCES EFFECTIVENESS OF REGISTRATION STATEMENT FILED WITH THE SEC
Auxilium Pharmaceuticals, Inc., (Nasdaq: AUXL - News), a specialty pharmaceutical company that develops and markets products for urology and sexual health, announced today that the Form S-3 (the "Registration Statement") it filed on August 12, 2005 in conjunction with its recent private placement has been declared effective by the Securities and Exchange Commission. The Registration Statement relates to 10,303,483 shares of Auxilium common stock, par value $0.01 per share, including 8,242,796 shares of common stock currently outstanding and held by the selling stockholders, and 2,060,687 shares of Common Stock issuable upon the exercise of warrants held by such selling stockholders.
Yahoo News (http://biz.yahoo.com/prnews/050912/nym162.html?.v=21)
Upcoming Events
-
07May
-
14May
-
30May